BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 23342257)

  • 1. Prevalence of human papillomavirus and survival in oropharyngeal cancer other than tonsil or base of tongue cancer.
    Marklund L; Näsman A; Ramqvist T; Dalianis T; Munck-Wikland E; Hammarstedt L
    Cancer Med; 2012 Aug; 1(1):82-8. PubMed ID: 23342257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low prevalence of p16-positive HPV-related head-neck cancers in Thailand: tertiary referral center experience.
    Nopmaneepaisarn T; Tangjaturonrasme N; Rawangban W; Vinayanuwattikun C; Keelawat S; Bychkov A
    BMC Cancer; 2019 Nov; 19(1):1050. PubMed ID: 31694600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of HPV prevalence in HNSCC patients with regard to regional and socioeconomic factors.
    Krupar R; Hartl M; Wirsching K; Dietmaier W; Strutz J; Hofstaedter F
    Eur Arch Otorhinolaryngol; 2014 Jun; 271(6):1737-45. PubMed ID: 24065189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double positivity for HPV DNA/p16 in tonsillar and base of tongue cancer improves prognostication: Insights from a large population-based study.
    Garnaes E; Frederiksen K; Kiss K; Andersen L; Therkildsen MH; Franzmann MB; Specht L; Andersen E; Norrild B; Kjaer SK; von Buchwald C
    Int J Cancer; 2016 Dec; 139(11):2598-605. PubMed ID: 27537425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of the concordance between p16 immunohistochemistry and HPV-PCR genotyping for the viral diagnosis of oropharyngeal squamous cell carcinoma.
    Fonmarty D; Cherrière S; Fleury H; Eimer S; Majoufre-Lefebvre C; Castetbon V; de Monès E
    Eur Ann Otorhinolaryngol Head Neck Dis; 2015 Jun; 132(3):135-9. PubMed ID: 25687724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in incidence and prevalence of human papillomavirus in tonsillar and base of tongue cancer during 2000-2016 in the Stockholm region and Sweden.
    Haeggblom L; Attoff T; Yu J; Holzhauser S; Vlastos A; Mirzae L; Ährlund-Richter A; Munck-Wikland E; Marklund L; Hammarstedt-Nordenvall L; Ye W; Ramqvist T; Näsman A; Dalianis T
    Head Neck; 2019 Jun; 41(6):1583-1590. PubMed ID: 30584688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absent/weak CD44 intensity and positive human papillomavirus (HPV) status in oropharyngeal squamous cell carcinoma indicates a very high survival.
    Näsman A; Nordfors C; Grün N; Munck-Wikland E; Ramqvist T; Marklund L; Lindquist D; Dalianis T
    Cancer Med; 2013 Aug; 2(4):507-18. PubMed ID: 24156023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strong association between infection with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden.
    Hansson BG; Rosenquist K; Antonsson A; Wennerberg J; Schildt EB; Bladström A; Andersson G
    Acta Otolaryngol; 2005 Dec; 125(12):1337-44. PubMed ID: 16303684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival of patients with oropharyngeal squamous cell carcinomas (OPSCC) in relation to TNM 8 - Risk of incorrect downstaging of HPV-mediated non-tonsillar, non-base of tongue carcinomas.
    Marklund L; Holzhauser S; de Flon C; Zupancic M; Landin D; Kolev A; Haeggblom L; Munck-Wikland E; Hammarstedt-Nordenvall L; Dalianis T; Näsman A
    Eur J Cancer; 2020 Nov; 139():192-200. PubMed ID: 32951963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologic importance and prognostic significance of selected clinicopathological parameters in patients with oral and oropharyngeal squamous cell carcinoma, with emphasis on smoking, protein p16(INK4a) expression, and HPV status.
    Laco J; Nekvindova J; Novakova V; Celakovsky P; Dolezalova H; Tucek L; Vosmikova H; Vosmik M; Neskudlova T; Cermakova E; Hacova M; Sobande FA; Ryska A
    Neoplasma; 2012; 59(4):398-408. PubMed ID: 22489695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RB1, p16, and Human Papillomavirus in Oropharyngeal Squamous Cell Carcinoma.
    Berdugo J; Rooper LM; Chiosea SI
    Head Neck Pathol; 2021 Dec; 15(4):1109-1118. PubMed ID: 33830464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPV-Positive Oropharyngeal Cancer Via p16 Immunohistochemistry in Japan.
    Toman J; Von Larson S; Umeno H; Kurita T; Furusaka T; Hasegawa H; Prasad ML; Sasaki CT
    Ann Otol Rhinol Laryngol; 2017 Feb; 126(2):152-158. PubMed ID: 27913709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus in oropharyngeal cancer in Canada: analysis of 5 comprehensive cancer centres using multiple imputation.
    Habbous S; Chu KP; Lau H; Schorr M; Belayneh M; Ha MN; Murray S; O'Sullivan B; Huang SH; Snow S; Parliament M; Hao D; Cheung WY; Xu W; Liu G
    CMAJ; 2017 Aug; 189(32):E1030-E1040. PubMed ID: 28808115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The changing incidence of human papillomavirus-associated oropharyngeal cancer using multiple imputation from 2000 to 2010 at a Comprehensive Cancer Centre.
    Habbous S; Chu KP; Qiu X; La Delfa A; Harland LT; Fadhel E; Hui A; Perez-Ordonez B; Weinreb I; Liu FF; Waldron J; O'Sullivan B; Goldstein D; Xu W; Huang SH; Liu G
    Cancer Epidemiol; 2013 Dec; 37(6):820-9. PubMed ID: 24184275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of p16 and HPV DNA in non-tonsillar, non-base of tongue oropharyngeal cancer.
    Hammarstedt L; Holzhauser S; Zupancic M; Kapoulitsa F; Ursu RG; Ramqvist T; Haeggblom L; Näsman A; Dalianis T; Marklund L
    Acta Otolaryngol; 2021 Jan; 141(1):89-94. PubMed ID: 32940116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of HPV-status on survival of patients with tonsillar carcinomas (TSCC) treated by CO
    Hoffmann M; Quabius ES; Tribius S; Gebhardt S; Görögh T; Hedderich J; Huber K; Dunst J; Ambrosch P
    Cancer Lett; 2018 Jan; 413():59-68. PubMed ID: 29100961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus infection and p16 overexpression in oropharyngeal squamous cell carcinoma: a case series from 2010 to 2014.
    Donà MG; Spriano G; Pichi B; Rollo F; Laquintana V; Covello R; Pellini R; Giuliani M; Pescarmona E; Benevolo M
    Future Microbiol; 2015; 10(8):1283-91. PubMed ID: 26228531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
    Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
    Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the presence of HPV related oropharyngeal and oral tongue squamous cell carcinoma in Mozambique.
    Blumberg J; Monjane L; Prasad M; Carrilho C; Judson BL
    Cancer Epidemiol; 2015 Dec; 39(6):1000-5. PubMed ID: 26590333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis.
    Weinberger PM; Yu Z; Haffty BG; Kowalski D; Harigopal M; Brandsma J; Sasaki C; Joe J; Camp RL; Rimm DL; Psyrri A
    J Clin Oncol; 2006 Feb; 24(5):736-47. PubMed ID: 16401683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.